ARTICLE | Company News
FDA approves Roxro's Sprix
May 18, 2010 12:17 AM UTC
FDA approved an NDA from Roxro Pharma Inc. (Menlo Park, Calif.) for Sprix ketorolac tromethamine nasal spray for short-term management of acute moderate to severe pain. Roxro said it is in negotiation...